Hai-Quan Mao

Cercano Management LLC /Private Equity/ (Cercano Management) is a venture capital subsidiary of Cercano Management LLC founded in 1986 by Paul Gardner Allen. The firm is headquartered in Bellevue, Washington.

Spiral Therapeutics, Inc. manufactures pharmaceutical products. The firm also develops therapies for inner ear disorders. The company was founded by Hugo Peris, Justin S. Hanes and Eugene de Juan in 2016 and is headquartered in San Francisco, CA.

Merz North America, Inc. operates as an specialty healthcare company. It offers treatment solutions for aesthetics, dermatology and neurosciences. The company was founded in 1908 and is headquartered in Raleigh, NC.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Foundry Therapeutics 1, Inc. engages in the development of pharmaceutical products. The company is headquartered in Menlo Park, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Camden Partners Private Equity (Camden Partners) is a private equity subsidiary of Camden Partners Holdings LLC founded in 1995 by David Lyle Warnock. The firm is headquartered in Baltimore, Maryland.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

Gliatech, Inc. engages in the discovery and development of bio surgery and pharmaceutical products. The company was founded on August 12, 1987 and is headquartered in Cleveland, OH.

MindX engages in developing games. The company is headquartered in United State.

WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD.

Sisu Global Health develops commercially scales and medical products. Its Hemafuse is a handheld, mechanical device for intraoperative autotransfusion of blood collected from an internal hemorrhage, meant to replace or augment donor blood in emergency situations. The company was founded by Carolyn Reed Yarina, Gillian Henker and Katie Kirsch and is headquartered in Baltimore, MD.

Kennedy Krieger Institute, Inc. provides services for children with developmental concerns mild to severe. Its services include patient care, research initiatives, special education, professional training, and community initiatives. The firm specializes in autism spectrum disorders, behavior disorders, brain injury, cerebral palsy, communication disorders, down syndrome, and sleep disorders. The company was founded in 1937 and is headquartered in Baltimore, MD.

Mind-X Corp. designs and develops software application. The firm offers MindX. The company was founded by R. Jacob Vogelstein, Julia Brown, and Emily Caporello Bluvas in 2017 and is headquartered in Bethesda, MD.

Part of Quest Diagnostics, Inc., Haystack Oncology, Inc. is a biopharmaceutical company based in Baltimore, MD. The Haystack MRD test is CLIA certified in the US and is available for biopharmaceutical clinical development in laboratories located in various locations. The company developed Haystack MRD™, a next-generation tumor-informed approach for the measurement of minimal residual disease. Haystack Oncology works with biopharmaceutical companies to advance important therapeutics to markets, from early phase clinical development to companion diagnostics. The test accelerates clinical development with better MRD testing unmatched sensitivity and specificity for confident MRD detection. The company leverages unmatched sensitivity and specificity to accelerate clinical trials and produce insights that drive biopharma pipeline development. The company was founded in 2021 by Kenneth W. Kinzler, Nickolas Papadopoulos, Joshua Cohen, Bert Vogelstein, and the CEO is Dan Edelstein. Haystack Oncology was acquired by Quest Diagnostics, Inc. on June 21, 2023 for $450 million.

Glyscend, Inc. engages in the development of therapeutics for treating metabolic diseases. It focuses on providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. The company was founded by Kevin Colbert in September 2014 and is headquartered in Baltimore, MD.

Seraxis Pte Ltd. provides biotechnology services. It offers a cure for insulin-dependent diabetes by replacing the lost insulin producing pancreatic cells with lab-grown cells, packaged within a device to protect the cells from immune rejection. The company was founded by William L. Rust in March 2013 and is headquartered in Singapore.

Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation

Nura, Inc. discovers and develops pharmaceutical products. It offers products for the treatment of neurodegenerative diseases such as Parkinson's & Alzheimer's diseases and behavioural disorders such as depression, anxiety, schizophrenia, obesity, and addiction. The company was founded in August 2003 and is headquartered in Seattle, WA.

Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA.

Cumbre Pharmaceuticals, Inc. discovers, develops, and markets anti-infective products for the treatment of serious and life-threatening infections, particularly caused by antibiotic resistant pathogens. Cumbre Pharmaceuticals was founded in 2001 and is headquartered in Dallas, TX

Johns Hopkins Medicine, Inc. owns and operates hospitals. It offers health care services in the areas of burn and wound care, cardiac surgery, cardiology, endocrinology, gastroenterology, gynecology/obstetrics, innovation in quality patient care, internal medicine, nephrology, neurology, neurosurgery, oncology, orthopedic surgery, otolaryngology-head and neck surgery. The company was founded by Johns Hopkins in 1997 and is headquartered in Baltimore, MD.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Johns Hopkins University Applied Physics Laboratory LLC is a not-for-profit center for engineering, research, and development. It offers services in air and missile defense, civilian space, cyber operations, homeland protection and national security analysis. The organization was founded in 1942 and is headquartered in Laurel, MD.

Seraxis Holdings, Inc. functions as an investment holding private company. The company is based in Germantown, MD. The CEO of the company is William L Rust.